These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34980974)

  • 21. Impact of Gene Expression Profiling on Decision-Making in Clinically Node Negative Melanoma Patients after Surgical Staging.
    Schuitevoerder D; Heath M; Cook RW; Covington KR; Fortino J; Leachman S; Vetto JT
    J Drugs Dermatol; 2018 Feb; 17(2):196-199. PubMed ID: 29462228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.
    Masarwy R; Shilo S; Carmel Neiderman NN; Kampel L; Horowitz G; Muhanna N; Mansour J
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
    Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
    Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do Largest Basal Tumor Diameter and the American Joint Committee on Cancer's Cancer Staging Influence Prognostication by Gene Expression Profiling in Choroidal Melanoma.
    Demirci H; Niziol LM; Ozkurt Z; Slimani N; Ozgonul C; Liu T; Musch DC; Materin M
    Am J Ophthalmol; 2018 Nov; 195():83-92. PubMed ID: 30081017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of Prognosis in Invasive Cutaneous Melanoma: An Independent Study of the Accuracy of a Gene Expression Profile Test.
    Greenhaw BN; Zitelli JA; Brodland DG
    Dermatol Surg; 2018 Dec; 44(12):1494-1500. PubMed ID: 29994951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
    Schefler AC; Koca E; Bernicker EH; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of a 31-gene expression profile for predicting outcomes in patients with primary cutaneous melanoma referred for sentinel node biopsy.
    Arnot SP; Han G; Fortino J; Han D; Fowler G; Vetto JT
    Am J Surg; 2021 Jun; 221(6):1195-1199. PubMed ID: 33773750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma.
    Arron ST; Wysong A; Hall MA; Bailey CN; Covington KR; Kurley SJ; Goldberg MS; Kasprzak JM; Somani AK; Ibrahim SF; Brodland DG; Cleaver NJ; Maher IA; Xia Y; Koyfman SA; Newman JG
    Laryngoscope Investig Otolaryngol; 2022 Feb; 7(1):135-144. PubMed ID: 35155791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
    Wysong A; Somani AK; Ibrahim SF; Cañueto J; Fitzgerald AL; Siegel JJ; Prasai A; Goldberg MS; Farberg AS; Regula C; Bar A; Kasprzak J; Brodland DG; Koyfman SA; Arron ST
    Dermatol Ther (Heidelb); 2024 Mar; 14(3):593-612. PubMed ID: 38424384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using Gene Expression Profiling to Personalize Skin Cancer Management.
    LeQuang JA
    J Clin Aesthet Dermatol; 2022 Nov; 15(11 Suppl 1):S3-S15. PubMed ID: 36405422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Metastatic Rates in GEP Class 1A versus 1B Posterior Uveal Melanoma: Results Contrary to Expectations.
    Augsburger JJ; Skinner CC; Correa ZM
    Ocul Oncol Pathol; 2023 Feb; 8(4-6):242-249. PubMed ID: 36925732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients.
    Ballhausen A; Urias E; Gruschkus SK; Williams M; Glover MS; Qin Y; Gombos DS; Patel SP
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the 31-Gene Expression Profile Test to Aid in the Decision of Adjuvant Treatment of Cutaneous Melanoma.
    Hunt J
    J Adv Pract Oncol; 2024 May; 15(4):277-280. PubMed ID: 39301099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 31-GEP (DecisionDx): a review of clinical utility and performance in a Mayo Clinic cohort.
    Pazhava A; Kim YH; Jing FZ; Pittelkow MR
    Int J Dermatol; 2024 Aug; ():. PubMed ID: 39154363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.
    Nguyen BT; Kim RS; Bretana ME; Kegley E; Schefler AC
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):421-427. PubMed ID: 29185101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test.
    Mirsky R; Prado G; Svoboda R; Glazer A; Rigel D
    J Drugs Dermatol; 2018 Nov; 17(11):1220-1223. PubMed ID: 30500144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Utility of the 31-Gene Expression Profile Test on the Management of Cutaneous Melanoma by Nurse Practitioners and Physician Assistants.
    Block R; Patterson D; Siegel JJ; Martin B; Quick AP; Hunt J
    J Adv Pract Oncol; 2023 Nov; 14(7):586-596. PubMed ID: 38196667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Utility of Dermoscopy and 31-Gene Expression Profiling by Dermatology Providers in Melanoma Management Care.
    Witkowski A; Lee C; Latour E; Vetto J; Ludzik J
    J Drugs Dermatol; 2022 Dec; 21(12):1347-1352. PubMed ID: 36468965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of a 31-Gene Expression Profile Into Clinical Decision-Making in the Treatment of Cutaneous Melanoma.
    Scott AM; Dale PS; Conforti A; Gibbs JN
    Am Surg; 2020 Nov; 86(11):1561-1564. PubMed ID: 32755379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma.
    Litchman GH; Fitzgerald AL; Kurley SJ; Cook RW; Rigel DS
    Curr Med Res Opin; 2020 Aug; 36(8):1295-1300. PubMed ID: 32372702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.